Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(80)
•••
bealert
X
View Profile
View Bullboard History
Comment by
bealert
on Jan 08, 2024 3:17am
RE:RE:RE:Expectations and milestones for 2024
Thanks for the acknowledgement Moneycollector. I received an email at 11:50 PM on Sunday night comparing TFC-1326 to Retinol. If this release doesn't move the needle a few points, I will be
...more
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Post by
LakeOromocto
on Jan 08, 2024 3:12am
New Tweet
https://twitter.com/SironaBiochem/status/1744255705131946082?t=JyRL4Amj48Zgf0VhQK9d7Q&s=19
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(16)
•••
moneycollector
X
View Profile
View Bullboard History
Comment by
moneycollector
on Jan 08, 2024 2:04am
RE:RE:Expectations and milestones for 2024
Well, how many consultants, advisors, board members and PR companies etc. have we seen come and go over the many years at Sirona? BeAlert is probably not completely off the mark when he subliminally
...more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 08, 2024 12:09am
RE:RE:Expectations and milestones for 2024
Either these strategic advisors are idiots or Howard just does not listen..... Sirona Biochem Retains Strategic Advisor To Commercialize Glycoproteins Published: Nov 03, 2015
...more
(80)
•••
bealert
X
View Profile
View Bullboard History
Comment by
bealert
on Jan 07, 2024 11:24pm
RE:Expectations and milestones for 2024
We have had some terrific news releases over the years which haven't materialized into anything we can take to the bank. That's 16.5 years folks, as I said in my recent posting. At the
...more
(11)
•••
Transperance
X
View Profile
View Bullboard History
Post by
Transperance
on Jan 07, 2024 3:50pm
Expectations and milestones for 2024
Prior to the 2023 BIO conference in Boston, it was stated that Sirona’s team had secured numerous meetings with organizations and companies (to be conducted during the conference) that possess
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Jan 04, 2024 11:03am
RE:RE:RE:SBM real value
Who knows since management doesn't disclose anything except that a deal was executed and it put a stupid smile on Howard's face. Allergan has to incorporate SBM's compound into their
...more
(41)
•••
Alex1726
X
View Profile
View Bullboard History
Comment by
Alex1726
on Jan 04, 2024 10:27am
RE:RE:SBM real value
Ok , so which one should apply to SBM? In a royality deal we should consider the higher one. Is 4% as a royality realistic?
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Jan 04, 2024 8:41am
RE:RE:SBM real value
All of their compounds are worthless if this bozo management never gets an actual product to market.
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jan 04, 2024 7:07am
RE:SBM real value
I think both articles is right. My interpretation is that the lower valuation refers to the substance sold to third party and the higher valuation to the actual product market value provided by third
...more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 04, 2024 12:36am
RE:SBM real value
Whatever the real value is, it's being discounted by 99% because bozo mgmt can't commercial squat.
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jan 04, 2024 12:18am
RE:SBM real value
Retinol increases sensitivity to UV rays so it is recommended as a night cream. 1326 protects cells from UV. See comparison chart. https://www.sironabiochem.com/programs/glycoprotemim/
(41)
•••
Alex1726
X
View Profile
View Bullboard History
Comment by
Alex1726
on Jan 03, 2024 10:32pm
RE:RE:SBM real value
So , how could it worth? Does $100M make sense, if not how much , if we suppose they're right about Retinol. Many more questions remains but......just wonder. Anyone would like to
...more
(41)
•••
Alex1726
X
View Profile
View Bullboard History
Comment by
Alex1726
on Jan 03, 2024 10:26pm
RE:SBM real value
If as they say: Sirona Biochem is certain that GlycoProteMim™ will surpass the current gold standard, Retinol, in its ability to reverse skin aging. Unlike other products on the market, GlycoProteMim™
...more
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >